期刊: ANTIVIRAL RESEARCH, 2023; 217 ()
Human cytomegalovirus (HCMV) can cause serious diseases in immunocompromised patients. Use of current antivirals is limited by their adverse effects a......
期刊: ANTIVIRAL RESEARCH, 2023; 219 ()
Yellow fever virus (YFV) infection is a major public concern that threatens a large population in South America and Africa. No specific antiviral drug......
期刊: ANTIVIRAL RESEARCH, 2023; 220 ()
New antiviral agents are needed for the treatment of hepatitis B virus (HBV) infection because currently available drugs do not completely eradicate c......
期刊: ANTIVIRAL RESEARCH, 2023; 214 ()
The emergence of SARS-CoV-2 variants represents a major threat to public health and requires identification of novel therapeutic agents to address the......
期刊: ANTIVIRAL RESEARCH, 2023; 216 ()
We have reported a lentivector which could effectively induce HBV-specific cytotoxic T lymphocytes (CTLs). Avasimibe is an inhibitor of acetyl-CoA ace......
期刊: ANTIVIRAL RESEARCH, 2023; 216 ()
Seasonal coronaviruses widely circulate in the global population, and severe complications can occur in specific vulnerable populations. Little is kno......
期刊: ANTIVIRAL RESEARCH, 2023; 220 ()
ZHX2 plays a crucial role in host immunity and modulates hepatitis B virus (HBV) replication. However, its correlation with immunomodulator-related tr......
期刊: ANTIVIRAL RESEARCH, 2023; 220 ()
With approximately 3.8 billion people at risk of infection in tropical and sub-tropical regions, Dengue ranks among the top ten threats worldwide. Des......
期刊: ANTIVIRAL RESEARCH, 2023; 220 ()
Despite global vaccination efforts, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve and spread globally. Currently, t......
期刊: ANTIVIRAL RESEARCH, 2023; 220 ()
Coronavirus Disease 2019 (COVID-19) pandemic is severely impacting the world, and tremendous efforts have been made to deal with it. Despite many adva......
期刊: ANTIVIRAL RESEARCH, 2023; 210 ()
Nucleoside/tide analogues (NAs) have long been used in the fight against viral diseases, and now present a promising option for the treatment of COVID......
期刊: ANTIVIRAL RESEARCH, 2023; 212 ()
Rapid emergence of new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has prompted an urgent need for the development of bro......
期刊: ANTIVIRAL RESEARCH, 2023; 213 ()
Chronic hepatitis B (CHB) patients treated with interferon shows encouraging results. However, its clinical ef-ficacy is limited by significant indivi......
期刊: ANTIVIRAL RESEARCH, 2023; 220 ()
Unravelling the molecular mechanism of COVID-19 vaccines through transcriptomic pathways involved in the host response to SARS-CoV-2 infection is key ......
期刊: ANTIVIRAL RESEARCH, 2023; 220 ()
Coronavirus (CoV) replication requires efficient cleavage of viral polyproteins into an array of non-structural proteins involved in viral replication......